SCHEMBL31079848

SCHEMBL31079848

O=C(NC1(C(F)F)CC1)c1ccc(F)c(F)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CES2 O00748 2/20 0.46
▸ CES1 P23141 2/20 0.46
▸ IDO1 P14902 1/20 0.45
▸ TAS1R3 Q7RTX0 1/20 0.43
▸ TAS1R1 Q7RTX1 1/20 0.43
▸ TAS1R2 Q8TE23 1/20 0.43
▸ HSD11B1 P28845 1/20 0.42
▸ KCNQ3 O43525 5/20 0.41
▸ KCNQ2 O43526 5/20 0.41
▸ KCNQ5 Q9NR82 1/20 0.41
▸ CYP11B1 P15538 1/20 0.40
▸ CYP11B2 P19099 1/20 0.40
▸ S1PR1 P21453 1/20 0.40
▸ S1PR3 Q99500 1/20 0.40
▸ CHRNA1 P02708 1/20 0.40
▸ CHRNG P07510 1/20 0.40
▸ CHRNB1 P11230 1/20 0.40
▸ CHRNB2 P17787 1/20 0.40
▸ SLC6A2 P23975 1/20 0.40
▸ CHRNB4 P30926 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31079886 0.78 HDAC1 (0.35) CES2CES1
SCHEMBL23243226 0.78 HDAC1 (0.35) CES2CES1
SCHEMBL21504283 0.75 TAS1R3 (0.49) CES2CES1IDO1TAS1R3TAS1R1
SCHEMBL31079679 0.72 HDAC4 (0.41) CES2CES1ALDH1A1
SCHEMBL23777375 0.72 GAA (0.35) CES2CES1ALDH1A1NPC1LMNA
SCHEMBL13146304 0.71 MLYCD (0.54) CES2CES1TAS1R3TAS1R1TAS1R2
SCHEMBL31079673 0.71 MLYCD (0.54) CES2CES1TAS1R3TAS1R1TAS1R2
SCHEMBL20147555 0.71 PLD1 (0.46) CES2CES1IDO1TAS1R3TAS1R1
SCHEMBL20069737 0.71 MEN1 (0.54) CES2CES1IDO1TAS1R3TAS1R1
SCHEMBL30929656 0.70 HDAC6 (0.69) CES2CES1KCNQ3KCNQ2KCNQ5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113227089-B Substituted 6-azabenzimidazole compounds as HPK1 inhibitors 吉利德科学公司 2024-07-05 — — CN disclosed
Send feedback